Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cystic fibrosis study tests Kids' core strength

NCT ID NCT06812793

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared muscle endurance in 48 children with cystic fibrosis (CF) and healthy children aged 6-18. Researchers measured core, respiratory, and leg muscle endurance to see if CF affects these abilities. The goal was to gather knowledge about physical differences, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

48 people

The number who actually took part.

Started

Feb 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Children diagnosed with cystic fibrosis and age matched healthy volunteers who do not have any diagnosed chronic diseases

Ages

6 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for Children with Cystic Fibrosis * Being between the ages of 6-18, * Being diagnosed with Cystic Fibrosis according to the American Cystic Fibrosis Association consensus guideline, * Having a forced expiratory volume in one second (FEV1) above 40% of the predicted value Exclusion Criteria for Children with Cystic Fibrosis * Not being able to cooperate with the assessment methods performed in the study * Having an orthopedic, neurological, vestibular, etc. problem that may negatively affect the assessment methods performed in the study * Having a history of exacerbation in the last month * Having an organ transplantation history * Using systemic corticosteroids Inclusion Criteria for Healthy Children \- Being between the ages of 6-18 Exclusion Criteria for Healthy Children * Not being able to cooperate with the assessment methods performed in the study * Having an orthopedic, neurological, vestibular, etc. problem that may negatively affect the assessment methods performed in the study * Having had a respiratory tract infection in the last month

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cystic fibrosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bezmialem Vakif University

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.